J&J seeks wider use of its Spravato antidepressant in USJohnson & Johnson has filed for US approval for a new claim on the label for its nasal Share XJ&J seeks wider use of its Spravato antidepressant in UShttps://pharmaphorum.com/news/jj-seeks-wider-use-of-its-spravato-antidepressant-in-us/